EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Utilization Review of Antihypertensive Agents at an Outpatient Pharmacy Setting of a Private Hospital, Selangor, Malaysia

Elammathi Ravinthiran, Ching Siang Tan, Shashidharan Menon, H. Jaasminerjiit Kaur, Anandarajagopal Kalusalingam, Abdullah Khan, Mohamad Mansor Manan, Khang Wen Goh, Mei Jun Loy, Long Chiau Ming

Progress in Drug Discovery & Biomedical Science · 2020

DOI: 10.36877/pddbs.a0000111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Progress in Drug Discovery & Biomedical Science, 2020. Verfasst von Elammathi Ravinthiran und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Drug utilization review of antihypertensive agents is regularly conducted to monitor the prescribing trends.

Objectives

The objectives of this study were to describe the drug utilization pattern of antihypertensive agents in the outpatient setting of a private hospital and to determine the defined daily dose (DDD) used by the private hospital in comparison to WHO DDD.

Method

This is a retrospective study using pharmacy dispensing record. Inclusion criteria were prescriptions issued in 2017, patients more than 18 years old. The DDD was calculated for each anti-hypertensive drug prescribed which was then compared with WHO DDD. Medicine prices were also analysed.

Results

From the total outpatient prescriptions in 2017, 200 prescriptions were chosen randomly using SPSS software. Based on the prescriptions analysed, the mean number of drugs prescribed per prescription was 3.89 (SD: 2.37). Beta blockers were the most prescribed group of anti-hypertensives (37%). Bisoprolol 5mg (9%) and furosemide 40mg (8.7%) were those drugs given to the most patients. Out of 330 drugs prescribed, 76% of them were non-fixed dose combination formula-tions. Of note, DDD of the 14% and 39% of the anti-hypertensive drugs analysed complied with and of doubled of the WHO DDD, respectively. Out of 330 anti-hypertensive drug products prescribed, 76% of them were non-FDC drugs.

Conclusion

Beta blockers are still commonly prescribed antihypertensive agents. Compared with similar studies from the last five years, prescribing of newer anti-hypertensive drugs is increased, as evidenced by certain FDC products doubled the DDD value recommended by WHO.

Zitieren

APA

Ravinthiran, E., Tan, C. S., Menon, S., Kaur, H. J., Kalusalingam, A., Khan, A., Manan, M. M., Goh, K. W., Loy, M. J., & Ming, L. C. (2020). Utilization Review of Antihypertensive Agents at an Outpatient Pharmacy Setting of a Private Hospital, Selangor, Malaysia. Progress in Drug Discovery & Biomedical Science. https://doi.org/10.36877/pddbs.a0000111

Vancouver

Ravinthiran E, Tan CS, Menon S, Kaur HJ, Kalusalingam A, Khan A, et al. Utilization Review of Antihypertensive Agents at an Outpatient Pharmacy Setting of a Private Hospital, Selangor, Malaysia. Progress in Drug Discovery & Biomedical Science. 2020. doi:10.36877/pddbs.a0000111

BibTeX
@article{Ravinthiran2020,
  author = {Ravinthiran, Elammathi and Tan, Ching Siang and Menon, Shashidharan and Kaur, H. Jaasminerjiit and Kalusalingam, Anandarajagopal and Khan, Abdullah and Manan, Mohamad Mansor and Goh, Khang Wen and Loy, Mei Jun and Ming, Long Chiau},
  title = {Utilization Review of Antihypertensive Agents at an Outpatient Pharmacy Setting of a Private Hospital, Selangor, Malaysia},
  journal = {Progress in Drug Discovery & Biomedical Science},
  year = {2020},
  doi = {10.36877/pddbs.a0000111}
}
Kostenlos starten →